RPRX logo

Royalty Pharma (RPRX) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$929.03 M
+$452.02 M+94.76%

December 31, 2024


Summary


Performance

RPRX Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$929.03 M
-$21.03 M-2.21%

December 31, 2024


Summary


Performance

RPRX Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRPRXbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

RPRX Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+94.8%+94.8%
3 y3 years-39.7%+94.8%
5 y5 years+277.4%+94.8%

RPRX Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.7%+94.8%-57.3%+94.8%
5 y5-year-45.7%+277.4%-62.0%+277.4%
alltimeall time-51.7%+277.4%-62.0%+277.4%

Royalty Pharma Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$929.03 M(+94.8%)
$929.03 M(-2.2%)
Sep 2024
-
$950.05 M(-46.2%)
Jun 2024
-
$1.76 B(+109.3%)
Mar 2024
-
$843.00 M(+76.7%)
Dec 2023
$477.01 M(-72.1%)
$477.01 M(-49.1%)
Sep 2023
-
$936.45 M(-56.9%)
Jun 2023
-
$2.17 B(+10.0%)
Mar 2023
-
$1.98 B(+15.5%)
Dec 2022
$1.71 B
$1.71 B(+72.5%)
Sep 2022
-
$991.63 M(-53.0%)
Jun 2022
-
$2.11 B(+17.7%)
DateAnnualQuarterly
Mar 2022
-
$1.79 B(+16.3%)
Dec 2021
$1.54 B(+52.8%)
$1.54 B(-14.4%)
Sep 2021
-
$1.80 B(+57.7%)
Jun 2021
-
$1.14 B(+61.2%)
Mar 2021
-
$708.81 M(-29.7%)
Dec 2020
$1.01 B(+309.7%)
$1.01 B(-35.0%)
Sep 2020
-
$1.55 B(-36.4%)
Jun 2020
-
$2.44 B(+291.3%)
Mar 2020
-
$624.37 M(+153.6%)
Dec 2019
$246.20 M(-87.2%)
$246.20 M
Dec 2018
$1.92 B
-

FAQ

  • What is Royalty Pharma annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Royalty Pharma?
  • What is Royalty Pharma annual cash & cash equivalents year-on-year change?
  • What is Royalty Pharma quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Royalty Pharma?
  • What is Royalty Pharma quarterly cash and cash equivalents year-on-year change?

What is Royalty Pharma annual cash & cash equivalents?

The current annual cash & cash equivalents of RPRX is $929.03 M

What is the all time high annual cash & cash equivalents for Royalty Pharma?

Royalty Pharma all-time high annual cash & cash equivalents is $1.92 B

What is Royalty Pharma annual cash & cash equivalents year-on-year change?

Over the past year, RPRX annual cash & cash equivalents has changed by +$452.02 M (+94.76%)

What is Royalty Pharma quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of RPRX is $929.03 M

What is the all time high quarterly cash and cash equivalents for Royalty Pharma?

Royalty Pharma all-time high quarterly cash and cash equivalents is $2.44 B

What is Royalty Pharma quarterly cash and cash equivalents year-on-year change?

Over the past year, RPRX quarterly cash and cash equivalents has changed by +$452.02 M (+94.76%)